New functional activities for the p21 family of CDK inhibitors

Genes and Development

Volumn 11, Issue 7, 1997, Pages 847-862

  Labaer, Joshua ^a   Garrett, Michelle D ^b   Stevenson, Lauren F ^a   Slingerland, Joyce M ^c   Sandhu, Charanjit ^c   Chou, Hubert S ^a   Fattaey, Ali ^b   Harlow, Ed ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b ONYX PHARMACEUTICALS   (United States)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

adaptors; CDK inhibitors; complex assembly; D type cyclin; immunodepletion; p21 and p27 families

Indexed keywords

CYCLINE; PROTEIN P21;

ARTICLE; BREAST EPITHELIUM; CELL CYCLE G0 PHASE; ENZYME ACTIVITY; ENZYME REGULATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY;

EID: 0030973878     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.7.847     Document Type: Article

References (66)

1. 1. Genes & Dev. 7: 812-821.
2. Brugarolas, J., C. Chandrasekaran, J.I. Gordon, D. Beach, T. Jacks, and G.J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
3. Chen, J., P.K. Jackson, M.W. Kirschner, and A. Dutta. 1995. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374: 386-388.
4. Chen, J., P. Saha, S. Kornbluth, B.D. Dynlacht, and A. Dutta. 1996. Cyclin-binding motifs are essential for the function of p21CIP1. Mol. Cell. Biol. 16: 4673-4682.
5. Clurman, B.E., R.J. Sheaff, K. Thress, M. Groudine, and J.M. Roberts. 1996. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes & Dev. 10: 1979-1990.
6. Deng, C., P. Zhang, J.W. Harper, S.J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
7. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
8. Enders, G.H., J. Koh, C. Missero, A.K. Rustgi, and E. Harlow. 1996. p16 inhibition of transformed and primary squamous epithelial cells. Oncogene 12: 1239-1245.
9. Ewen, M.E., H.K. Sluss, L.L. Whitehouse, and D.M. Livingston. 1993. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74: 1009-1020.
10. Flørenes, V.A., N. Bhattacharya, M.R. Bani, Y. Ben-David, R.S. Kerbel, and J.M. Slingerland. 1996. TGFβ mediated G1 arrest in a human melanoma cell line lacking p15INK4B: Evidence for cooperation between p21Cip1/WAF1 and p27KIP1. Oncogene 13: 2447-2457.
11. Geng, Y. and R.A. Weinberg. 1993. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. 90: 10315-10319.
12. Gerber, M.R., A. Farrell, R.J. Deshaies, I. Herskowitz, and D.O. Morgan. 1995. Cdc37 is required for association of the protein kinase Cdc28 with G1 and mitotic cyclins. Proc. Natl. Acad. Sci. 92: 4651-4655.
13. Goubin, F. and B. Ducommun. 1995. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene 10: 2281-2287.
14. Grussenmeyer, T., K.H. Scheidtmann, M.A. Hutchinson, W. Eckhart, and G. Walter. 1985. Complexes of polyoma virus medium T antigen and cellular proteins. Proc. Natl. Acad. Sci. 82: 7952-7954.
15. Gu, Y., C.W. Turck, and D.O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710.
16. Hall, M., S. Bates, and G. Peters. 1995. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11: 1581-1588.
17. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
18. Harper, J.W., S.J. Elledge, K. Keyomarsi, B. Dynlacht, L.H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, et al. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6: 387-400.
19. Hinds, P.W., S. Mittnacht, V. Dulic, A. Arnold, S.I. Reed, and R.A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993-1006.
20. Hu, Q., C. Bautista, G. Edwards, D. Defeo-Jones, R. Jones, and E. Harlow. 1991. Antibodies specific for the human retinoblastoma protein identify a family of related polypepides. Mol. Cell. Biol. 11: 5792-5799.
21. Kato, I.-Y., M. Matsuoka, D.K. Strom, and C.J. Sherr. 1994. Regulation of cyclin D-dependent kinases (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14: 2713-2721.
22. King, R.W., P.J. Jackson, and M.W. Kirschner. 1994. Mitosis in transition. Cell 79: 563-571.
23. Koh, J., G.H. Enders, B.D. Dynlacht, and E. Harlow. 1995. Tumor-derived p16 alleles encoding proteins defective in cell cycle inhibition. Nature 375: 506-510.
24. Li, R., S. Waga, G.J. Hannon, D. Beach, and B. Stillman. 1994. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534-537.
25. Li, R., G.J. Hannon, D. Beach, and B. Stillman. 1996. Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage. Curr. Biol. 6: 189-199.
26. Lin, J., C. Reichner, X. Wu, and A.J. Levine. 1996. Analysis of wild-type and mutant p21WAF-1 gene activities. Mol. Cell. Biol. 16: 1786-1793.
27. Liu, Y., J.L. Martindale, M. Gorospe, and N.J. Holbrook. 1996. Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res. 56: 31-35.
28. Lukas, J., D. Jadayel, J. Bartkova, E. Nacheva, M.J. Dyer, M. Strauss, and J. Bartek. 1994. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation. Oncogene 9: 2159-2167.
29. Luo, Y., J. Hurwitz, and J. Massague. 1995. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375: 159-161.
30. MacArthur, H. and G. Walter. 1984. Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen. J. Virol. 52: 483-491.
31. Macleod, K.F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-Dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes & Dev. 9: 935-944.
32. Makela, T.P., J.-P. Tassan, E.A. Nigg, S. Frutiger, G.J. Hughes, and R.A. Weinberg. 1994. A cyclin associated with the CDK-activating kinase MO15. Nature 371: 254-257.
33. Mantel, C., Z. Luo, J. Canfield, S. Braun, C. Deng, and H.E. Broxmeyer. 1996. Involvement of p21CIP1 and p27KIP1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21CIP1 in the maintenance of stem/progenitor cells in vivo. Blood 88: 3710-3719.
34. Matsushime, H., M.F. Roussel, R.A. Ashmun, and C.J. Sherr. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701-713.
35. PSK-J3/cdk4) for mammalian D type cyclins. Cell 71: 323-334.
36. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14: 2066-2076.
37. Meyerson, M. and E. Harlow. 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell Biol. 14: 2077-2086.
38. Michieli, P., M. Chedid, D. Lin, J.H. Pierce, W.E. Mercer, and D. Givol. 1994. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54: 3391-3395.
39. Morgan, D.O. 1995. Principles of CDK regulation. Nature 374: 131-134.
40. Motokura, T. and A. Arnold. 1993. Cyclin D and oncogenesis. Curr. Opin. Genet. Dev. 3: 5-10.
41. Nakanishi, M., R.S. Robetorye, G.R. Adami, O.M. Pereira-Smith, and J.R. Smith. 1995. Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/ WAF1. EMBO J. 14: 555-563.
42. Noda, A., Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell. Res. 211: 90-98.
43. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570-573.
44. Nurse, P. 1994. Ordering S phase and M phase in the cell cycle. Cell 79: 547-550.
45. Peters, G. 1994. The D-type cyclins and their role in tumori-genesis. J. Cell. Sci. (Suppl.) 18: 89-96.
46. Poon, R.Y.C., W. Jiang, H. Toyoshima, and T. Hunter. 1996. Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage. J. Biol. Chem. 271: 13283-13291.
47. Qin, X.Q., T. Chittenden, D.M. Livingston, and W.G. Kaelin Jr. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes &. Dev. 6: 953-964.
48. Russo, A.A., P.D. Jeffrey, A.K. Patten, J. Massague, and N.P. Pavletich. 1996. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382: 325-331.
49. Sherr, C.J. 1994. G1 phase progression: Cycling on cue. Cell 79: 551-556.
50. _. 1996. Cancer cell cycles. Science 274: 1672-1677.
51. 1 cyclin-dependent kinases. Genes & Dev. 9: 1149-1163.
52. Soos, T.J., H. Kiyokawa, J.S. Yan, M.S. Rubin, A. Giordano, A. DeBlasio, S. Bottega, B. Wong, J. Mendelsohn, and A. Koff. 1996. Formation of p27-cdk complexes during the human mitotic cell cycle. Cell Growth Differ. 7: 135-146.
53. Stampfer, M.J. 1985. Isolation and growth of human mammary epithelial cells. J. Tissue Cult. Methods 9: 107-115.
54. Stampfer, M.R. and J.C. Bartley. 1985. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc. Natl. Acad. Sci. 82: 2394-2398.
55. Stampfer, M.R., C.H. Pan, J. Hosoda, J. Bartholomew, J. Mendelsohn, and P. Yaswen. 1993. Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle. Exp. Cell. Res. 208: 175-188.
56. Stepanova, L., X. Leng, S.B. Parker, and J.W. Harper. 1996. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes & Dev. 10: 1491-1502.
57. Tournier, S., D. Leroy, F. Goubin, B. Ducommun, and J.S. Hyams. 1996. Heterologous expression of the human cyclin-dependent kinase inhibitor p21Cip1 in the fission yeast, Schizosaccharomyces pombe reveals a role for PCNA in the chk1+ cell cycle checkpoint pathway. Mol. Biol. Cell. 7: 651-662.
58. Toyoshima, H. and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74.
59. van den Heuvel, S. and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050-2054.
60. Warbrick, E., D.P. Lane, D.M. Glover, and L.S. Cox. 1995. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr. Biol. 5: 275-282.
61. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993a. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
62. Xiong, Y., H. Zhang, and D. Beach. 1993b. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes & Dev. 7: 1572-1583.
63. Zhang, H., G.J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes &. Dev. 8: 1750-1758.
64. Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes & Dev. 7: 1111-1125.
65. Zhu, L., G. Enders, J.A. Lees, R.L. Beijersbergen, R. Bernards, and E. Harlow. 1995a. The pRB-related protein p107 contains two growth suppression domains: Independent interactions with E2F and cyclin/cdk complexes. EMBO J. 14: 1904-1913.
66. CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes & Dev. 9: 1740-1752.